Lili Yang

897 total citations
28 papers, 743 citations indexed

About

Lili Yang is a scholar working on Epidemiology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Lili Yang has authored 28 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 15 papers in Molecular Biology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Lili Yang's work include Liver Disease Diagnosis and Treatment (18 papers), Diet, Metabolism, and Disease (6 papers) and Alcohol Consumption and Health Effects (5 papers). Lili Yang is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Diet, Metabolism, and Disease (6 papers) and Alcohol Consumption and Health Effects (5 papers). Lili Yang collaborates with scholars based in China, United States and Serbia. Lili Yang's co-authors include Haiyan Song, Guang Ji, Peiyong Zheng, Defeng Wu, Arthur I. Cederbaum, Li Zhang, Xiaodong Wang, Xiaodong Wang, Tao Liu and Chunlei Zhang and has published in prestigious journals such as Hepatology, Scientific Reports and Cochrane Database of Systematic Reviews.

In The Last Decade

Lili Yang

28 papers receiving 734 citations

Peers

Lili Yang
Marina Galicia‐Moreno Mexico
Lindsei K. Sarna Canada
Yumei Fu United States
Ting Bai China
Quan Jin China
Marı́a Teresa Ronco Argentina
Takanobu Takata Japan
Amro El‐Karef Egypt
Marina Galicia‐Moreno Mexico
Lili Yang
Citations per year, relative to Lili Yang Lili Yang (= 1×) peers Marina Galicia‐Moreno

Countries citing papers authored by Lili Yang

Since Specialization
Citations

This map shows the geographic impact of Lili Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lili Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lili Yang more than expected).

Fields of papers citing papers by Lili Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lili Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lili Yang. The network helps show where Lili Yang may publish in the future.

Co-authorship network of co-authors of Lili Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Lili Yang. A scholar is included among the top collaborators of Lili Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lili Yang. Lili Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deng, Hongyong, Lili Yang, Lujin Li, et al.. (2024). Vitamin E for people with non-alcoholic fatty liver disease. Cochrane Database of Systematic Reviews. 2024(10). CD015033–CD015033. 10 indexed citations
2.
Hai, Yang, Ke Ren, Lili Yang, et al.. (2024). HIF-1α serves as a co-linker between AD and T2DM. Biomedicine & Pharmacotherapy. 171. 116158–116158. 10 indexed citations
3.
Yang, Lili, et al.. (2024). Scoparone alleviates nonalcoholic fatty liver disease by modulating the PPARα signaling pathway. European Journal of Pharmacology. 984. 177033–177033. 3 indexed citations
4.
Li, Yiping, Yang Liu, Zhiwei Chen, et al.. (2023). Protopanaxadiol ameliorates NAFLD by regulating hepatocyte lipid metabolism through AMPK/SIRT1 signaling pathway. Biomedicine & Pharmacotherapy. 160. 114319–114319. 20 indexed citations
5.
Liu, Yang, et al.. (2022). Salvia-Nelumbinis naturalis improves lipid metabolism of NAFLD by regulating the SIRT1/AMPK signaling pathway. BMC Complementary Medicine and Therapies. 22(1). 213–213. 12 indexed citations
6.
Zhou, Yan, Feng Ya, Lili Yang, et al.. (2022). High-fat diet combined with dextran sulfate sodium failed to induce a more serious NASH phenotype than high-fat diet alone. Frontiers in Pharmacology. 13. 1022172–1022172. 4 indexed citations
7.
Liao, Xinyi, Lili Yang, Chunlei Zhang, et al.. (2022). Extract of Marsdenia tenacissima (Roxb.) Moon [Apocynaceae] Suppresses Hepatocellular Carcinoma by Inhibiting Angiogenesis. Frontiers in Pharmacology. 13. 900128–900128. 6 indexed citations
8.
Chen, Zhiwei, et al.. (2022). The potential function and clinical application of FGF21 in metabolic diseases. Frontiers in Pharmacology. 13. 1089214–1089214. 46 indexed citations
9.
Yang, Lili, et al.. (2022). Scoparone Improves Nonalcoholic Steatohepatitis Through Alleviating JNK/Sab Signaling Pathway-Mediated Mitochondrial Dysfunction. Frontiers in Pharmacology. 13. 863756–863756. 18 indexed citations
10.
Yang, Lili, et al.. (2022). Lanzhang Granules Ameliorate Nonalcoholic Fatty Liver Disease by Regulating the PPARα Signaling Pathway. Evidence-based Complementary and Alternative Medicine. 2022. 1–15. 3 indexed citations
11.
Yang, Lili, Yan Zhou, Haiyan Song, & Peiyong Zheng. (2019). Jiang-Zhi granules decrease sensitivity to low-dose CCl4 induced liver injury in NAFLD rats through reducing endoplasmic reticulum stress. BMC Complementary and Alternative Medicine. 19(1). 228–228. 14 indexed citations
12.
Zhu, Mingzhe, Wenjun Zhou, Tao Liu, et al.. (2018). Integrated analysis of hepatic mRNA and miRNA profiles identified molecular networks and potential biomarkers of NAFLD. Scientific Reports. 8(1). 7628–7628. 30 indexed citations
13.
14.
Wei, Xiaoyun, et al.. (2016). The Therapeutic Effect of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta‐Analysis. Evidence-based Complementary and Alternative Medicine. 2016(1). 3593951–3593951. 67 indexed citations
15.
Li, Meng, Hanchen Xu, Chunlei Zhang, et al.. (2016). Integrative analysis of metabolome and gut microbiota in diet-induced hyperlipidemic rats treated with berberine compounds. Journal of Translational Medicine. 14(1). 237–237. 100 indexed citations
16.
Song, Haiyan, et al.. (2013). Bioactivity of five components of Chinese herbal formula Jiangzhi granules against hepatocellular steatosis. Journal of Integrative Medicine. 11(4). 262–268. 27 indexed citations
17.
Yang, Lili, Defeng Wu, Xiaodong Wang, & Arthur I. Cederbaum. (2012). Cytochrome P4502E1, oxidative stress, JNK, and autophagy in acute alcohol-induced fatty liver. Free Radical Biology and Medicine. 53(5). 1170–1180. 74 indexed citations
18.
Wu, Defeng, et al.. (2012). Alcohol steatosis and cytotoxicity: The role of cytochrome P4502E1 and autophagy. Free Radical Biology and Medicine. 53(6). 1346–1357. 82 indexed citations
19.
20.
Song, Haiyan, Zhimin Mao, Lili Yang, et al.. (2011). Dangfei Liganning Capsules () Attenuate the Susceptibility of Rat Nonalcoholic Fatty Liver to Carbon Tetrachloride Toxicity. Journal of Traditional Chinese Medicine. 31(4). 327–333. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marina Galicia‐Moreno Breakdown of academic impact, for papers by Lindsei K. Sarna Breakdown of academic impact, for papers by Yumei Fu Breakdown of academic impact, for papers by Ting Bai Breakdown of academic impact, for papers by Quan Jin Breakdown of academic impact, for papers by Marı́a Teresa Ronco Breakdown of academic impact, for papers by Takanobu Takata Breakdown of academic impact, for papers by Amro El‐Karef
Rankless by CCL
2026